Alliance Pharma

www.alliancepharma.co.uk Financials
  • Watchlist/Portfolio

    Add to watchlist:

    Only registered members can add into watchlist !

    Register here !
Overview
Financials (in $m unless stated)
Sales 45.957
EBITDA -
Operating Profit 12.339
Pre-tax Profit 10.712
Net Profit 8.636
Capex -
Operating Cash Flow 10.158
Net Working Capital -
Key Ratios
EBITDA Margin -
Operating Profit Margin 26.8%
Net Profit Margin 18.8%
Capex/Sales (%) -
NWC/Sales (%) 0.0x
Asset Turnover 0.6x
Days Inventory 96 days
Days Receivable -
Days Payable 236 days
Performance (Last 3 Years)
Sales CAGR -
EBITDA CAGR -
Operating Profit CAGR -
Profit CAGR -
Return on Equity
Return on Assets -
Return on Invested Capital (ROIC) -
ROIC - WACC -
Valuation
Market Cap 69.77 m
Price to Earnings 7.32
Price to Book Value -
Price to Tangible Book -
Equity to FCF Yield -
Enterprise Value 106.853
EV to Sales -
EV to EBITDA -
EV to Operating Profit -
EV to Invested Capital -
EV to FCF Yield -
Dividend Yield 0.83
Payout Ratio 0.21
Per Share Data (in GBp unless stated)
Earnings per share (31/12/11) 3.62
Operating Cashflow per share -
Free Cashflow per share -
Dividend per share 0.75
NAV per share -
Cash per share -
Solvency
Intangibles Incl. Excl.
Net debt to Equity % 45.1% -
Cash to Equity % 0.0x -
Gross debt to Equity % 46.4% -
Gross Debt < 1 Year to Equity - -
Net debt to Assets % 35.5x
Net Debt/EBITDA - -
Net Interest Cover - -
Op Cashflow Interest Cover - -
Current Ratio 1.11054188614 -
Quick Ratio 0.702720253987 -
Cash Ratio 0.0778555451331 -
Dividend Cover 5.28 -
Key Dates
Latest Dividend Pay date 12/07/12
Latest Ex-Dividend date 13/06/12
Last Annual Results 31/12/11
Last Interim Results 30/06/11